Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astera Labs (ALAB) Common Equity (2023 - 2025)

Astera Labs (ALAB) has disclosed Common Equity for 3 consecutive years, with $1.4 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 41.34% year-over-year to $1.4 billion, compared with a TTM value of $1.4 billion through Dec 2025, up 41.34%, and an annual FY2025 reading of $1.4 billion, up 41.34% over the prior year.
  • Common Equity was $1.4 billion for Q4 2025 at Astera Labs, up from $1.3 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.4 billion in Q4 2025 and bottomed at -$117.3 million in Q2 2023.
  • Average Common Equity over 3 years is $657.5 million, with a median of $867.4 million recorded in 2024.
  • The sharpest move saw Common Equity skyrocketed 1087.5% in 2024, then increased 28.78% in 2025.
  • Year by year, Common Equity stood at -$97.7 million in 2023, then surged by 1087.5% to $964.8 million in 2024, then surged by 41.34% to $1.4 billion in 2025.
  • Business Quant data shows Common Equity for ALAB at $1.4 billion in Q4 2025, $1.3 billion in Q3 2025, and $1.1 billion in Q2 2025.